Metraipolis › archive › dc_13f87f564b65

Comparative safety of ustekinumab versus anti-TNF therapy during pregnancy in patients with inflammatory bowel disease: A systematic review and meta-analysis — Europe PMC PMID:40958297

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40958297
DOI
10.1097/md.0000000000044393
License (as archived)
solo-consultazione
Archived
2026-11-10T05:40:14.624Z
SHA-256 of the archived text
9e2dfcf4741925f336f703e31771a652c01c9b5854880d6bcd99ccc9a174e3d2
Stable URL of this page
https://metraipolis.com/documento/dc_13f87f564b65

How to cite

Comparative safety of ustekinumab versus anti-TNF therapy during pregnancy in patients with inflammatory bowel disease: A systematic review and meta-analysis — Europe PMC PMID:40958297 — Europe PMC (en), https://europepmc.org/article/MED/40958297 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_13f87f564b65 (Metraipolis archive dc_13f87f564b65, sha256 9e2dfcf4741925f336f703e31771a652c01c9b5854880d6bcd99ccc9a174e3d2)
BibTeX
@misc{dc13f87f564b65,
  title = {Comparative safety of ustekinumab versus anti-TNF therapy during pregnancy in patients with inflammatory bowel disease: A systematic review and meta-analysis — Europe PMC PMID:40958297},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40958297},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_13f87f564b65; sha256 9e2dfcf4741925f336f703e31771a652c01c9b5854880d6bcd99ccc9a174e3d2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40958297. Agents can read the archived copy with the MCP tool read_document.